Neostigmine Methylsulfate – Cholinesterase Inhibitor API
Basic Information
▸ CAS Number: 80449-31-6
▸ Standard: In-House / IP / EP / BP Standard
Applications
1. Myasthenia Gravis Treatment
First-line treatment for autoimmune neuromuscular weakness, alleviating fatigue, ptosis, and generalized weakness by improving neuromuscular communication.
2. Reversal of Neuromuscular Blockade
Used postoperatively to reverse muscle relaxants administered during surgery, often with an anticholinergic like atropine.
3. Treatment for Acute Urinary Retention
Promotes bladder contraction in cases of postoperative or neurogenic urinary retention.
4. Increased Gastrointestinal Motility
Helps treat post-operative ileus and neurogenic bowel dysfunction by enhancing peristalsis and alleviating hypomotility.
5. Ophthalmic Use
Topical application may induce miosis and reduce intraocular pressure to help manage certain glaucoma conditions.
6. Research Applications
Used in experimental studies to investigate neuromuscular transmission, cholinergic pathways, and synaptic mechanisms.
Conclusion
Neostigmine Methylsulfate is a versatile and essential pharmaceutical for clinical and research applications. By enhancing cholinergic function, it effectively manages neuromuscular disorders, supports perioperative recovery, and aids urinary and gastrointestinal motility. Its use should always be supervised by qualified healthcare professionals to ensure proper dosing and minimize side effects.
Hot Tags: neostigmine methylsulfate for animals, China neostigmine methylsulfate for animals manufacturers, suppliers, factory, Maropitant CAS 147116 67 4, Altrenogest CAS 850 52 2, Pradofloxacin CAS 195532 12 8, animal treatment small molecular substances for drug discovery, Toceranib CAS 356068 94 5, small molecule agents for veterinary drug discovery
